Objectives: Many antibiotics used to treat infections cause release of immunostimulatory cell wall components from bacteria. Therefore, a combination of antimicrobial and endotoxin-neutralizing activity is desired to prevent inflammation induced by destroyed bacteria. Chlorhexidine and alexidine are amphipathic bisbiguanides and could neutralize bacterial membrane components as stimulators of Toll-like receptors (TLRs).
Introduction
Lipopolysaccharide (LPS) from Gram-negative bacteria and lipoteichoic acid (LTA), lipopeptides and peptidoglycan (PG) from Gram-positive bacteria are able to induce activation of cells of the immune system, leading to inflammation.
1,2 Those bacterial components are released either by the body's natural defence molecules or by the action of antibiotics. Upon recognition of immunostimulatory cell-wall components by the immune surveillance cells, numerous inflammatory mediators are produced that lead to inflammation, which can cause serious pathological consequences. 3 Antimicrobial agents represent the most important treatment for bacterial infection, but they are often insufficient, since we have few effective endotoxin-neutralizing therapies available that can sequester LPS or LTA and prevent excessive response by the innate immune system. 4 One possible approach to prevent unregulated overproduction of inflammatory mediators by pathogenic bacteria is to target LPS and LTA by the use of agents that bind to and sequester them. The toxic centre of the LPS molecule, the predominant structural component of the Gram-negative bacterial outer membrane, is a glycolipid moiety lipid A, which is composed of a hydrophilic, bis-phosphorylated diglucosamine backbone and a hydrophobic domain containing six (Escherichia coli) or seven (Salmonella sp.) acyl chains. 5 In the case of Gram-positive bacteria and the short-chain-length exocellular LTA, the glycolipid anchor that contains six glycerophosphate units is a more potent activator of the immune system than integral LTA, but is, however, significantly less potent than LPS. 6 Polycationic amphiphilic molecules, such as lipopolyamines, polymyxin B, sulphonamides and peptides and others, have been shown to bind and neutralize LPS. 7 -14 The structural motif required for lipid A neutralization comprises the two centres of positive charge, separated by a distance matching the distance between phosphate groups of lipid A ($15 Å ) with an additional hydrophobic moiety for interaction with the acyl chains of lipid A. 10, 15, 16 Some lipoproteins and peptides have recently shown promising results for neutralization of endotoxin. 17 -19 The aim of the present study was to investigate whether widely used bisbiguanides, alexidine and chlorhexidine, are able to bind the bacterial agonists of receptors of innate immunity, LPS and LTA, and neutralize immunostimulatory cell wall components released by conventional antibiotics. Alexidine and chlorhexidine are cationic hydrophobic bisbiguanides used as biocides and antiseptics.
Chlorhexidine has been shown to bind and neutralize LPS. 10, 20 It is probably the most widely used biocide in antiseptic products, in particular, in hand washing and oral products, but also as a disinfectant and preservative. 21 It is active towards a wide range of Gram-positive and Gram-negative bacteria and is compatible with a variety of commonly used antibiotics. 22 There have been few reports of chlorhexidine resistance at the concentrations currently in use, in spite of its widespread use for almost 50 years in clinical and domestic settings, and only small changes in MIC have been noted. 22 Alexidine differs chemically from chlorhexidine by the presence of two ethylhexyl end groups, as opposed to the p-chlorophenyl moieties of chlorhexidine. Alexidine has antimicrobial activity towards Gram-positive and Gram-negative bacteria and tumour cell-specific properties. 23 Alexidine is used as a disinfectant in mouthwash solutions and contact lens solutions. 24 In comparison with chlorhexidine, it has faster bactericidal activity and also produces a significantly faster bacterial permeabilization. 21 No LPS or LTA neutralization has been previously reported for alexidine.
This study shows that both compounds bind to LPS and LTA using several biophysical methods. Both neutralize macrophage activation by antibiotic-killed Gram-negative and Gram-positive bacteria or LPS/LTA-mediated cell activation.
Materials and methods

Cell culture and reagents
Alexidine was obtained from Gentaur (France) and chlorhexidine from Sigma (St Louis, USA). BODIPY-cadaverine was from Molecular probes (The Netherlands), propidium iodide from Fluka (Switzerland) and LTA, lipid A and LPS from Sigma. A stock solution of LTA (10 mg/mL) and LPS (1.5 mg/mL) was prepared in water and lipid A (5 mg/mL) in chloroform/methanol/water, 74:23:3. E. coli (NCTC 8007, serotype O111 K58) was provided by Dr Ignacio Moriyon, University of Navarra, Pamplona, Spain, and Staphylococcus aureus subsp. 
Determination of BODIPY-cadaverine displacement
Fluorescence measurements were performed on a luminescence spectrometer LS55 (PerkinElmer Life Sciences) at room temperature in a quartz cuvette of 1 cm path length. The excitation wavelength for BODIPY-cadaverine was 580 nm and fluorescence emission was measured at 620 nm. To determine the displacement assay, we mixed 1 mM BODIPY-cadaverine in Tris buffer ( pH 7.4, 50 mM) with 5 mg/L S-LPS or 15 mg/L LTA and added small volume aliquots of dissolved compounds. We calculated the percent of displacement of BODIPY-cadaverine with bisbiguanides at different concentrations in comparison with the LPS (LTA) and BODIPYcadaverine mixture.
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Calorimetric titration of bisbiguanides and LPS/LTA by isothermal titration calorimetry Microcalorimetric measurements of alexidine or chlorhexidine interaction with S-LPS, lipid A and LTA were performed on a Microcal isothermal titration calorimeter (VT-ITC MicroCalorimeter). The LPS sample at a concentration of 30 or 50 mM in 10 mM Tris, pH 7.0, was filled into the microcalorimetric cell (volume 1.44 mL) and 300 mM alexidine or 750 mM chlorhexidine into the syringe (280 mL). Calorimetric titration curve for lipid A and LTA was determined by titrating 25 mM lipid A with 375 mM alexidine or 40 mM lipid A with 600 mM chlorhexidine, and 27 mM LTA with 405 mM alexidine or 50 mM LTA and 750 mM chlorhexidine. After thermal equilibration, aliquots of 3 mL were injected every 6 min into the endotoxin-containing cell with constant stirring. The total heat signal from each experiment was determined as the area under the individual peaks and plotted versus the [bisbiguanide]/[endotoxin] molar ratio. As a control for the isothermal titration calorimetry (ITC) experiments, alexidine and chlorhexidine were titrated into the buffer. 26 
Neutralization of LPS activation of MD-2-transfected HEK-BF1 cells
HEK-BF1 cells were cultured in DMEM (Invitrogen, San Diego, CA, USA) supplemented with antibiotic [0.5 mg/mL G418 (Sigma)] and 10% fetal bovine serum (BioWhittaker, Walkersville, MD, USA) at 378C under 5% CO 2 . For the transfection assay, cells were plated on 96-well Costar plates (Corning, The Netherlands) at 7Â10 4 cells per 100 mL. After 24 h, they were transfected with 80 ng per well of NF-kB-dependent luciferase, 5 ng of constitutively active Renilla reporter plasmid and 10 ng of plasmid of human MD-2, kindly provided by Dr Kensuke Miyake (University of Tokyo, Japan) using Lipofectamine 2000 (Invivogen). The medium was changed after 24 h and 100 ng/mL of LPS from Salmonella abortus equi HL83 (kindly provided by Dr Klaus Brandenburg Forschungszentrum Borstel, Germany) and chlorhexidine or alexidine at a concentration of 5-0.1 mg/L were added. After overnight incubation, the medium was removed and cells were lysed by passive lysis buffer (Promega, Madison, WI, USA) and analysed for reporter gene activity using a dual luciferase reporter assay system on a Mithras LB940 luminometer (Berthold). Relative luciferase activity (RLA) was calculated by normalizing the firefly luciferase activity of each sample by constitutive Renilla luciferase activity measured within the same sample by the standard luciferase assay protocol.
27,28
Neutralization of LTA activation of TLR2-transfected HEK cells HEK293 cells were maintained in DMEM, 10% FBS and antibiotic [penicillin 100 IU/mL and streptomycin 100 mg/L (Invitrogen) at 378C under 5% CO 2 ]. For the transfection assay, cells were plated on 96-well plates at 5Â10 4 cells per 100 mL and transfected after 24 h using Lipofectamine 2000 according to the manufacturer's instruction and 50 ng of human TLR2 [kindly provided by Dr Carsten Kirschning (Technische Universität, Munich, Germany)], 80 ng of NF-kB-dependant luciferase and 5 ng of constitutive Renilla reporter plasmids per well. Cells were grown for 24 h; the medium was then changed and stimulated with 10 mg/L LTA and chlorhexidine or alexidine at a concentration of 5-0.1 mg/L. 27 After the overnight incubation, the medium was removed and cells were lysed by passive lysis buffer (Promega) and analysed for reporter gene activity using a dual luciferase reporter assay system on a Mithras LB940 luminometer (Berthold). RLA was calculated by normalizing each sample's luciferase activity for constitutive activity measured within the same sample. Statistical significance was assessed by one-tailed Student's t-test as implemented in a Microsoft Excel program.
Inhibition of NO production by RAW264 cells by E. coli and S. aureus
RAW264 cells were cultured in RPMI (Invitrogen), 12% FBS and antibiotics [ penicillin 100 IU/mL and streptomycin 100 mg/L (Invitrogen)]. For the neutralization assay, 2Â10 5 cells per 55 mL were incubated for 24 h with 100 mM carboxy-PTIO (Sigma) and 55 mL of bacteria in the RPMI medium. [An overnight bacterial culture was diluted in fresh Luria-Bertani medium and allowed to grow to an optical density at 600 nm (OD 600 ) of 0.6.] E. coli cells at an OD 600 of 0.6 were 1:1200 diluted with an RPMI medium, S. aureus cells at an OD 600 of 0.6 were 1:20 diluted. Ampicillin for E. coli or chloramphenicol for S. aureus was added to a final concentration of 50 mg/L and 10 mL of different concentrations of chlorhexidine or alexidine were added. After 24 h, we measured the amount of NO by the Griess reagent (Sigma).
2, 29, 30 Cell viability in the presence of bacteria and bisbiguanides was tested with propidium iodide. The cell suspension (5Â10 5 cells/mL) was washed with ice-cold PBS and centrifuged at 48C and 500 g for 5 min. The cell pellet was resuspended in PBS and kept on ice, after propidium iodide had been added. The final concentration of propidium iodide was 3 mM. The cells were transferred to a sample cup and analysed with flow cytometer (Epics Altra, Coulter), where the fraction of dead bacteria was assessed from the fraction of stained versus nonstained cell populations seen in the histogram.
Results
Determination of alexidine and chlorhexidine binding to LPS and LTA
We examined the binding of alexidine and chlorhexidine (Figure 1 ) to LPS and LTA using a rapid and robust fluorescence displacement assay based on binding of BODIPY-cadaverine to LPS as described previously. 25 We have extended this assay in our work to determine binding to LTA. The addition of alexidine and chlorhexidine resulted in dequenching displaced BODIPYcadaverine previously bound to LPS or LTA, which manifested in emission intensity enhancement. Both compounds are able to displace BODIPY-cadaverine at a concentration between 0.1 and 70 mg/L; however, alexidine is able to displace an appreciably larger amount of the dye from both S-LPS and LTA than chlorhexidine at the same concentrations as shown in Figure 2(a and b) .
Calorimetric titration of alexidine and chlorhexidine interaction with LPS, lipid A and LTA Direct interaction of bisbiguanides with LPS and LTA was also determined by isothermal titration calorimetry. 31 This method provides additional information on the nature of the interaction and stoichiometry of binding sites. It uses an instrument to compensate for the heat absorbed or released by the interaction of titrated aliquots of selected compounds infected into the solution of lipid A (Figure 3) . Titration was performed by 3 mL injections of a 600 mM chlorhexidine solution into 40 mM lipid A solution every 6 min, and the calorimetric signal was recorded. The peaks directed downwards (Figure 3 ) are characteristic for an exothermic process. The results of alexidine and chlorhexidine binding to S-LPS are shown in Figure 4 . The interaction between both compounds and S-LPS is endothermic in the initial stages of titration, suggesting that there is an entropically driven interaction up to $0.4 molar equivalents for both compounds, and switches to exothermic reaction for the remaining measured injections. Both bisbiguanides were titrated against the endotoxic principle lipid A to elucidate the interaction between lipid A and tested compounds (Figure 4) . The calorimetric titration curve for binding to lipid A indicates at least two types of binding sites of differing affinities for each compound. For the first few injections up to $0.2 molar equivalents, the reaction is endothermic and then switches to exothermic for the remaining injections, such as previously determined for LPS. 
Zorko and Jerala
In contrast, the heat of interaction between alexidine or chlorhexidine and LTA is exothermic, characteristic of electrostatically driven interactions ( Figure 5 ), indicating differences in interaction between LPS, the predominant component of Gramnegative bacteria, and LTA, a component of Gram-positive bacteria.
Neutralization of LPS-and LTA-mediated cell activation through Toll-like receptors
LPS and LTA as cell membrane components of Gram-negative and Gram-positive bacteria, respectively, activate cells by engaging with different cell-membrane TLRs. Alexidine and chlorhexidine inhibit S-LPS-induced activation of NF-kB proinflammatory transcription factor as detected by the dual luciferase assay using reporter plasmids ( Figure 6 ). This assay also detects and accounts for the potential toxicity of compounds on different efficiency values of receptor transfection for mammalian cells. HEK293 cells transfected with TLR4/MD-2 and TLR2 were used to determine neutralization of biological activity of LPS and LTA, respectively. Chlorhexidine inhibits the cell activation by LPS in a concentration-dependent manner, reaching almost full inhibition at a concentration of 5 mg/L, in comparison with alexidine, which shows only slightly decreased inhibition. Both tested bisbiguanides inhibit TLR2 activation by LTA even at 0.1 mg/L, and maximal inhibition is reached at 1 mg/L. However, it did not reach such a high fraction as in the case of LPS and TLR4/MD2.
Bisbiguanide inhibition of macrophage activation of E. coli and S. aureus treated with antibiotics
To determine whether alexidine and chlorhexidine are able to neutralize immunostimulatory cell-wall components released from Gram-negative and Gram-positive bacteria by 'conventional antibiotics', E. coli was treated with ampicillin and S. aureus with chloramphenicol above their MIC. The addition of antibiotics that killed bacteria resulted in a significant increase in macrophage activation as seen by the production of NO. Co-incubation of E. coli or S. aureus together with ampicillin or chloramphenicol and murine macrophage cell line RAW264.7 in the presence of alexidine and chlorhexidine resulted in a decrease in produced NO in comparison with treatment of bacterial culture with only conventional antibiotics ( Figure 7 ).
The viability of cells was tested for each concentration of alexidine and chlorhexidine used. In contrast to TLR2-transfected HEK293 cells stimulated with LTA, bisbiguanides achieved almost complete inhibition of activation by Gram-positive bacteria.
Discussion
Alexidine and chlorhexidine are bisbiguanide compounds with antimicrobial activity against a wide range of Gram-positive and Gram-negative bacteria. Both compounds are mainly used for topical applications, such as in oral hygiene products or for topical treatment against wound sepsis. 32 The bisbiguanides show ability to neutralize the immunostimulatory cell wall of E. coli and S. aureus. This work demonstrated that alexidine binds to LPS and LTA better than chlorhexidine does. The BODIPY-cadaverine displacement assay is a rapid method to screen for LPS-binding molecules, but it is dominated by electrostatic interactions between LPS and its ligand so it is not always an accurate reporter of hydrophobic interaction, which is an essential determinant of biological neutralization. 10, 16 This assay has been adapted to evaluate binding to LTA. More accurate characterization of binding characteristics was provided by calorimetric titration. This method has previously been used for the analysis of antimicrobial peptide binding to LPS. 26,33 -35 In the initial stages of titration, the endothermic process was observed for LPS binding of both compounds. This suggests an entropy-driven process, probably predominantly due to the rearrangement of the solvent (hydrophobic interaction). Titration curves for LPS with bisbiguanides approach zero only at a high molar ratio (data not shown), most likely due to the presence of several anionic-binding sites at the O-antigen of LPS, whose saturation, however, is not required for the neutralization of biological activity. Analysis of calorimetric titration yielded an association constant of 2.9Â10 6 and 2.2Â10 5 M
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for alexidine and chlorhexidine, respectively. Lipid A as the minimal required structural element for stimulating endotoxic activity exhibited both exothermic and endothermic interaction, probably due to the initial disruption of hydrophobic aggregates and binding to the charged bisphosphate polar head group of lipid A. Titration showed a 1:1 stoichiometry for the binding of both compounds to lipid A. The first part of the titration curve represents an endothermic process and the second part an exothermic process. It is likely that disruption of hydrophobically anchored lipid A aggregates is achieved first followed by the endothermic process, due to the electrostatic interaction between the negative charge of lipid A and the positive charge of alexidine and chlorhexidine. The equilibrium binding constant determined from ITC is higher for alexidine than for chlorhexidine, which is in agreement with the stronger affinity of alexidine for lipid A determined in the BODIPY-cadaverine assay. Alexidine contains two hydrophobic ethylhexyl groups, whereas chlorhexidine has p-chlorophenyl end groups. Therefore, hydrophobic interaction between alexidine and the hydrophobic acyl chains in lipid A may be stronger due to the more favourable packing of alkyl chains of alexidine than that of the p-chlorophenyl group of chlorhexidine ( Figure 1 ). Titration curves for binding of alexidine and chlorhexidine to LTA indicate multiple binding sites. The affinity of alexidine for LTA is stronger than that of chlorhexidine. Results of cell activation show a slightly better endotoxin neutralization for chlorhexidine than for alexidine in the case of LPS neutralization, while both show similar LTA-neutralizing activity. Differences between cellular and in vitro binding assays on isolated components could be due to several factors of the complex biological system, such as binding to serum components, aggregation state of compounds and the resulting differences in the availability of the monomer etc.
Both bisbiguanides are able to neutralize immunostimulatory cell-wall components released from bacteria after bactericidal activity of antibiotics based on different mechanisms. Concentrations of alexidine and chlorhexidine, which are able to neutralize proinflammatory stimulators such as LTA and LPS, are similar and more than 100 times lower than that used in typical topical applications.
It has been shown that chlorhexidine is effective in treating bacterial biofilms. 32 In this respect, the ability of bisbiguanides to neutralize the stimulation of the innate immune response is particularly interesting as biofilm disruption by conventional antibiotics may lead to the extensive release of immunostimulatory bacterial cell wall components. 36 Bisbiguanides could be used in combination with antibiotics at significantly lower concentrations than those usually used in topical applications. In this case, the role of bisbiguanide would be to neutralize the released proinflammatory constituents of bacteria killed by the antibiotic. Previous research on innate immune system activators has emphasized LPS, but as the large segment of bacterial infections originates from Gram-positive bacteria, 31, 37, 38 neutralization of bacterial cell wall mediators has to be considered. Results from this study on the differences in the binding interactions may provide information for the development of better inhibitors of LTA.
The difference in hydrophobic moieties between these two compounds is thought to be responsible for the more rapid bactericidal action of alexidine, as well as the ability of this bisbiguanide to induce lipid-phase separation and domain formation at bacterial membranes. Chlorhexidine affects membrane integrity at low concentrations and causes the cytoplasm to congeal at higher concentrations. 21, 39, 40 Previous studies of alexidine and chlorhexidine have shown their toxicity for a variety of mammalian cells, although at significantly higher concentrations than used here. 20, 23 This study suggests that the efficiency of both compounds, particularly in topical applications, are at least in part due to the effective suppression of cell activation in addition to their biocidal activity.
